<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Testimony of David J. Graham, 			  MD, MPH&lt;br&gt;			  &lt;font size="3"&gt; November 18, 2004&lt;/font&gt;</title><link>http://articles.mercola.com/sites/articles/archive/2005/03/02/david-graham-testimonial.aspx</link><description>Mr. Chairman and members of the Committee, Introduction Good morning. My name is David Graham, and I am pleased to come before you today to speak about Vioxx, heart attacks and the FDA. By way of introduction, I graduated from the Johns Hopkins University</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>